18 This is the rst large scale double-blind, randomized, placebo-controlled, noninferiority trial that provides robust evidence on the cardiovascular safety of topical testosterone replacement therapy. The results will enable clinicians to make a more informed evaluation of the potential benets and risks of testosterone therapy for this group of men. Availability of testosterone gel in South Africa Testosterone 1% gel (ANDROGEL®) is currently the only registered testosterone gel in South Africa. Useful Links to further information: https://www.urotoday.com/videolectures/journal-club/video/mediaitem/3579traverse-trial-insights-a-comprehensive-look-attestosterone-replacement-therapy-andcardiovascular-safety-journal-club-rashidsayyid-zachary-klaassen.html https://live.arealive.org/webinars/public/index. html#home Standardising Terminology What terminology should we be using for abiraterone, enzalutamide, apalutamide and darolutamide? These drugs are currently referred to as: • Androgen receptor pathway inhibitor (ARPI) • Androgen receptor signaling inhibitors (ARSI) • Androgen receptor-targeted agents (ARTA) • Second generation androgen receptor pathway inhibitors (SARPI) • New hormonal agents (NHA) • Novel hormonal therapies (NHT) Androgen receptor pathway inhibitor (ARPI) At a recent meeting of the Advanced Prostate Cancer Consensus Conference 58% of the participants voted for this term. This was endorsed by the SAUA. Conclusion This is an appeal to clinicians, presenters and the pharmaceutical industry to use one name for these drugs in South Africa to avoid confusion UROLOGY, URO-ONCOLOGY AND SEXOLOGY UPDATE
RkJQdWJsaXNoZXIy NTIyOTQ=